TY  - JOUR
AU  - Narros-Fernández, Paloma
AU  - Chioua, Mourad
AU  - Petcu, Sonia
AU  - Diez-Iriepa, Daniel
AU  - Cerrada-Gálvez, Laura
AU  - Decouty-Pérez, Céline
AU  - Palomino Antolín, Alejandra
AU  - Ramos Alonso, Eva
AU  - Farré-Alins, Victor
AU  - López-Rodríguez, Ana Belén
AU  - Romero Martínez, Manuel Alejandro
AU  - Marco Contelles, José Luis
AU  - Egea, Javier
PY  - 2022
DO  - 10.1021/acs.jmedchem.2c00149
UR  - https://hdl.handle.net/20.500.14352/116946
T2  - Journal Of Medicinal Chemistry
AB  - NLRP3 is involved in the pathophysiology of several inflammatory diseases. Therefore, there is high current interest in the clinical development of new NLRP3 inflammasome small inhibitors to treat these diseases. Novel N-sulfonylureas were obtained by...
LA  - eng
M2  - 6250
PB  - ACS Publications
TI  - Synthesis and pharmacological evaluation of new n‑nulfonylureas as nlrp3 inflammasome inhibitors: identification of a hit compound to treat gout
TY  - journal article
VL  - 65
ER  -